Steroids for Rhinoplasty: Pain, Nausea, Edema and Ecchymosis
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Jun 25, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a medication called methylprednisolone, a type of steroid, on patients undergoing rhinoplasty, which is a surgery to reshape the nose. Researchers want to find out if taking this steroid can help reduce pain, nausea, swelling, and bruising after the surgery, as well as improve the overall experience for patients. While previous studies have shown that steroids can help with swelling and bruising, this trial aims to see if they can also make a difference in how much pain patients feel and how they feel overall after their surgery.
To be eligible for this study, participants must be at least 18 years old and planning to have their first rhinoplasty surgery without any other facial procedures or sinus surgeries happening at the same time. Unfortunately, people who have had previous nose surgeries, have certain medical conditions (like diabetes or liver problems), or are pregnant cannot take part in this study. If you join the trial, you can expect to be monitored for pain, nausea, and other symptoms after your surgery, helping doctors understand how effective the steroid treatment might be. This research is important because it could lead to better recovery experiences for future rhinoplasty patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults at least 18 years of age who elect to undergo cosmetic or functional open primary rhinoplasty with/without osteotomies (repositioning the nasal bones)
- • No other facial plastics procedure nor sinus surgery performed simultaneously.
- Exclusion Criteria:
- • revision rhinoplasty
- • diabetic patients
- • patients with an allergy to steroids
- • use of PPE implants
- • parents receiving concurrent sinus surgery
- • patients receiving biologics or preop oral steroids
- • Patients that are pregnant or attempting to conceive
- • Liver failure or cirrhosis
- • Diagnosis of hypothyroidism
- • Diagnosis of glaucoma
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Priyesh N Patel, MD
Principal Investigator
Vanderbilt University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported